AcelRx to Host Second Quarter 2021 Financial Results Call and Webcast on August 16, 2021PRNewsWire • 08/09/21
ACRX Final Deadline Monday: Rosen, a Trusted and Leading Law Firm, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRXNewsfile Corp • 08/06/21
DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/06/21
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)Business Wire • 08/06/21
MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/05/21
MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmNewsfile Corp • 08/04/21
ACRX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: August 9, 2021Newsfile Corp • 08/04/21
ROSEN, A TOP RANKED LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRXBusiness Wire • 08/03/21
Will AcelRx Pharmaceuticals (ACRX) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 08/02/21
ACRX Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds AcelRx Pharmaceuticals, Inc. Investors of Class Action and Lead Plaintiff Deadline: August 9, 2021Business Wire • 08/02/21
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)PRNewsWire • 07/28/21
AcelRx Pharmaceuticals: How The Licensing Agreements Could Become A Shot In The ArmSeeking Alpha • 07/27/21
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - ACRXPRNewsWire • 07/27/21
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against AcelRx Pharmaceuticals, Inc. (ACRX)PRNewsWire • 07/23/21
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of AcelRx Pharmaceuticals, Inc. (ACRX) InvestorsPRNewsWire • 07/21/21
ACRX Investor Notice: Rosen, Trusted Investor Counsel, Encourages AcelRx Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ACRXNewsfile Corp • 07/20/21
ACRX ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRXNewsfile Corp • 07/17/21
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action – ACRXBusiness Wire • 07/16/21
ROSEN, A LEADING LAW FIRM, Encourages AcelRx Pharmaceuticals, Inc. Investors to Secure Counsel Before Important August 9 Deadline in Securities Class Action - ACRXNewsfile Corp • 07/14/21
AcelRx, Aguettant Ink Licensing Agreements For Dzuveo And Two Prefilled Syringe ProductsBenzinga • 07/14/21
AcelRx Enters into Licensing Agreement for DZUVEO® in Europe and In-licensing Agreement for Two Products in the U.S.PRNewsWire • 07/14/21
SHAREHOLDER ALERT: Robbins LLP Reminds Investors of a Class Action Against AcelRX Pharmaceuticals, Inc. (ACRX)Newsfile Corp • 07/08/21
